IRIS PHARMA

IRIS PHARMA is a pharmaceutical company specializing in ocular drug and ophthalmic medical device development. With 32 years of experience in ophthalmology research, the company offers a wide range of services including therapeutic effect assessment, value addition to drug candidates, development plan design, and clinical development services. IRIS PHARMA has a remarkable track record with over 70 FDA, PMDA & EMA new ocular drug approvals and ophthalmic medical device marketing authorizations. The company prides itself on its state-of-the-art medical and scientific equipment, highly specialized staff, and compliance with industry standards including GLP and GCLP. Founded in 1989, IRIS PHARMA collaborates with start-up companies, biotechnology firms, large pharmaceutical companies, pharmaceutical labs, universities, research organizations, and consultants in the field of ophthalmology. With a "Solutions for every challenge in ocular drug and ophthalmic medical device development" approach, IRIS PHARMA has positioned itself as a key player in the pharmaceutical industry.